Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone Propionate

This study evaluates whether the market withdrawal of brand-name fluticasone propionate was associated with discontinuation of inhaled steroid therapy in children.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2025-04-26
DOI
https://doi.org/10.1001/jama.2025.4154
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone Propionate

Rena M. Conti, Anna Volerman, Kao‐Ping Chua
JAMA
Asthma and respiratory diseases
article

Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone Propionate

Rena M. Conti, Anna Volerman, Kao‐Ping Chua
article en

Abstract

This study evaluates whether the market withdrawal of brand-name fluticasone propionate was associated with discontinuation of inhaled steroid therapy in children.

JAMAVol. 333(23)
Boston University (US), University of Michigan (US), University of Chicago (US)
Openalex Percentile: Top 89%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.